More on DSGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.8 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Design Therapeutics Inc. (NQ:DSGN)
Delayed: 15.14 --0 (-0%)
Prev. Close $15.14  
Open$15.14 
52 Wk High$ 
52 Wk Low$ 
Day High$15.14 
Day Low$15.14 
P/E N/A  
EPS$ 
Volume2,264 

Friends, Peers and Foes (?): XENE, CMPS, ABBV, ABVX, ANNX (more...)

Sep 2, 2026 08:00 AM Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
Aug 14, 2026 04:13 PM Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
Aug 14, 2026 08:33 AM Form SCHEDULE 13G Design Therapeutics, Filed by: Sirenia Capital Management LP
Aug 3, 2026 04:08 PM Design Therapeutics, Inc. (DSGN) Tops Q2 EPS by 3c
Aug 3, 2026 08:08 AM Form 10-Q Design Therapeutics, For: Jun 30
Aug 3, 2026 08:04 AM Form 8-K Design Therapeutics, For: Aug 03
Aug 3, 2026 08:04 AM Design Therapeutics modifies Friedreich ataxia trial, posts Q2 2026 loss
Aug 3, 2026 08:00 AM Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results 
Jul 1, 2026 06:59 AM Design Therapeutics (DSGN) Reiterated at Overweight by Cantor Fitzgerald
Jun 30, 2026 08:00 AM Design Therapeutics begins patient dosing in Phase 1 DT-818 trial
View All Articles

Entities mentioned with DSGN

View All Entities